A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of a Novel Formulation of 5% Minoxidil Topical Foam Versus Placebo in the Treatment of Androgenetic Alopecia in Men

    Elise A. Olsen, David A. Whiting, Wilma F. Bergfeld … Bruce Kohut
    Studysummary This study found that a new 5% minoxidil foam formulation significantly increased hair counts and improved hair loss condition in men with androgenetic alopecia over 16 weeks compared to placebo.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on linkinghub.elsevier.com →
    Discuss this study in the Community →

    Research cited in this study 7

    1. A Randomized Clinical Trial of 5% Topical Minoxidil Versus 2% Topical Minoxidil and Placebo in the Treatment of Androgenetic Alopecia in Men Journal of The American Academy of Dermatology · 2002
    2. Photographic Documentation of Hair Growth in Androgenetic Alopecia Dermatologic Clinics · 1999
    3. Finasteride in the Treatment of Men with Androgenetic Alopecia Journal of The American Academy of Dermatology · 1998
    4. Androgenetic Alopecia in the Female: Treatment with 2% Topical Minoxidil Solution Archives of Dermatology · 1994
    5. Use of Topical Minoxidil Therapy for Androgenetic Alopecia in Women International Journal of Dermatology · 1993
    6. Topical Minoxidil in Early Male Pattern Baldness Journal of The American Academy of Dermatology · 1985
    7. Topical Minoxidil Therapy in Hereditary Androgenetic Alopecia Archives of Dermatology · 1985

    Related research 10

    1. A Survey of Patient Attitudes Towards Topical Minoxidil in the Treatment of Hair Loss PubMed · 2022
    2. Sisaipho Alopecia Areata Treated With Tofacitinib and Oral Minoxidil JAAD case reports · 2022
    3. Role of Low Dose Oral Minoxidil in the Treatment of Hair Loss: A Review Cosmoderma · 2021
    4. Efficacy of Systemic Minoxidil and Tofacitinib Combination in Treatment-Resistant Alopecia Universalis Journal of Cosmetic Dermatology · 2020
    5. A Randomized, Single-Blind Trial of 5% Minoxidil Foam Once Daily Versus 2% Minoxidil Solution Twice Daily in the Treatment of Androgenetic Alopecia in Women Journal of The American Academy of Dermatology · 2011
    6. A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of a Novel Formulation of 5% Minoxidil Topical Foam Versus Placebo in the Treatment of Androgenetic Alopecia in Men Journal of The American Academy of Dermatology · 2007
    7. Androgenetic Alopecia in the Female Archives of Dermatology · 1994
    8. Use of Topical Minoxidil Therapy for Androgenetic Alopecia in Women International Journal of Dermatology · 1993
    9. Treatment of Female Androgenetic Alopecia with Minoxidil 2% International Journal of Dermatology · 1992
    10. Topical 2% Minoxidil Solution in Male Pattern Alopecia: The Initial European Experience International Journal of Dermatology · 1988